Parathyroid Glands

Slide 1 · Parathyroid Glands

Normal structure, calcium homeostasis, and clinicopathologic correlations

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

At the end of this lecture, learners should be able to:

Identify normal parathyroid locations, chief cells, oxyphil cells, and age-related stromal fat.

Explain how PTH regulates calcium and phosphate through kidney, gut, and bone.

Distinguish autonomous, compensatory, and deficient parathyroid function.

Interpret major morphologic and biochemical patterns of parathyroid disease.

Slide 3 · Four small glands near the thyroid

Parathyroid anatomy is variable despite a familiar usual arrangement.

Typically four glands lie near the upper and lower poles of the thyroid lobes.

Parathyroid tissue is anatomically distinct from thyroid follicular tissue.

An ectopic gland may be overlooked if only the usual neck locations are considered.

Thyroid lobes

Parathyroids shown in red

Slide 4 · Pharyngeal pouch descent explains ectopic sites

Embryologic migration determines the range of normal locations.

The glands arise from pharyngeal pouches related embryologically to the thymus.

Parathyroid tissue may occur along the descent pathway.

Documented ectopic locations include carotid sheath, thymus, and anterior mediastinum.

Pharyngeal pouches

Migration / descent

Neck • thymus • mediastinum

Schematic — not a histologic specimen

Slide 5 · From embryology to operative anatomy

The route of descent creates practical implications for gland localization.

Pharyngeal pouch origin

Migration toward cervical thyroid region

Usual superior/inferior sites

Possible ectopic cervical or mediastinal glands

An anatomically “missing” gland may be ectopic rather than absent.

Slide 6 · Chief cells dominate normal parathyroid

Chief cells are the principal hormone-secreting cell population.

Polygonal cells approximately 12–20 μm in diameter.

Central, round, relatively uniform nuclei.

Light-to-dark pink cytoplasm; Cytoplasmic secretory granules contain PTH.

Chief-cell population

Schematic — not a histologic specimen

Slide 7 · Chief-cell granules contain PTH

Function is linked directly to normal cell architecture.

The hormone is stored in secretory granules in chief cells.

Circulating ionized calcium regulates synthesis and release of PTH.

Normal endocrine morphology must be interpreted together with calcium–PTH physiology.

Chief-cell population

Schematic — not a histologic specimen

Slide 8 · Oxyphil cells have distinctive cytoplasm

The oxyphil population differs from chief cells in size and organelles.

Oxyphil and transitional oxyphil cells occur singly or in small clusters.

They are slightly larger than chief cells, with eosinophilic cytoplasm.

The eosinophilia corresponds to numerous mitochondria; Secretory granules are sparse or absent.

Oxyphil cells (mitochondria-rich)

Schematic — not a histologic specimen

Slide 9 · Oxyphil biology: Avoid overinterpretation

Oxyphil cells have specialized features, but their principal physiologic role is less defined.

Oxyphil cells express abundant calcium-sensing receptors.

Proposed oxyphil products include PTH-related protein and calcitriol.

These observations should not be equated with chief-cell PTH secretion.

Chief-cell population

Schematic — not a histologic specimen

Slide 10 · Age affects the appearance of a normal gland

Stromal fat is a normal component that changes after childhood.

Early-infant and childhood glands consist largely of solid sheets of chief cells.

Adipose stromal tissue increases through young adulthood.

Stromal fat reaches approximately 30% by about age 25, then plateaus.

Normal tissue: Epithelial cells + fat

Schematic — not a histologic specimen

Slide 11 · Normal parathyroid architecture: A schematic

Assess epithelial cells together with interspersed adipose tissue.

Chief cells form the predominant epithelial component.

Oxyphil cells are admixed singly or in small groups.

Adipose tissue becomes conspicuous in a typical adult gland.

Normal tissue: Epithelial cells + fat

Schematic — not a histologic specimen

Slide 12 · Chief cells versus oxyphil cells

Cytoplasmic staining, organelles, and distribution distinguish normal cell populations.

Feature

Chief cells

Oxyphil cells

Relative abundance

Predominant

Scattered or small clusters

Cytoplasm

Light to dark pink

Strongly eosinophilic

Nucleus

Round, central, uniform

Similar; Cell is somewhat larger

Characteristic organelles

PTH-containing granules

Numerous mitochondria

Normal cell populations can coexist in the same gland.

Slide 13 · PTH is the principal calcium-regulating output

Parathyroid secretion is regulated by circulating free (ionized) calcium.

Low circulating ionized calcium stimulates PTH synthesis and secretion.

PTH increases free calcium through coordinated effects on kidney, vitamin D, and bone.

Rising calcium inhibits further PTH secretion.

↓ Ionized calcium

↑ PTH secretion

↑ Serum free calcium

Negative feedback ↓ PTH

Slide 14 · The physiological negative-feedback loop

A fall in free calcium initiates a corrective endocrine response.

↓ Ionized calcium

↑ Chief-cell PTH secretion

Calcium-conserving and mobilizing actions

↑ Ionized calcium → PTH suppression

Homeostasis depends on the response of the glands to the free, not merely total, calcium level.

Slide 15 · Why ionized calcium matters

PTH secretion is coupled to the biologically free fraction.

The normal regulatory signal is blood ionized calcium.

Hypocalcemia prompts secretion rather than suppression of PTH.

Interpret any measured PTH concentration relative to the concurrent calcium level.

Ionized Ca²⁺ decreases

Chief cells release PTH

Ca²⁺ restores → PTH declines

Slide 16 · The kidney conserves calcium under PTH

Renal handling is one direct route to restoring extracellular calcium.

PTH enhances renal tubular reabsorption of calcium.

Conservation limits urinary calcium loss from the filtered load.

This action contributes to the rise in circulating free calcium.

PTH at renal tubule

↑ Calcium reabsorption

↑ Circulating calcium

Slide 17 · PTH promotes phosphate excretion

The renal phosphate response differs from the calcium response.

PTH increases urinary excretion of phosphate.

Serum phosphate consequently tends to fall when this pathway is effective.

Phosphate binds calcium: Changing phosphate availability affects free calcium.

PTH at renal tubule

↑ Phosphate excretion

↓ Serum phosphate

Slide 18 · Renal effects of PTH are directionally opposite

Both changes contribute to calcium homeostasis.

Renal target

Response to PTH

System consequence

Calcium handling

Reabsorption increases

Conserves circulating calcium

Phosphate handling

Urinary excretion increases

Tends to lower phosphate

Kidney activation of vitamin D

Conversion increases

Supports intestinal calcium uptake

Do not assume that PTH increases renal retention of all minerals.

Slide 19 · The kidney activates vitamin D in response to PTH

Indirect intestinal effects begin in the kidney.

PTH increases conversion of vitamin D to its active dihydroxy form.

Active vitamin D enhances gastrointestinal calcium absorption.

Reduced kidney function can disrupt this endocrine linkage.

PTH stimulates kidney

↑ Active vitamin D

↑ Gut calcium uptake

Slide 20 · The vitamin D arm links kidney and gut

This is an indirect route for PTH to increase circulating calcium.

PTH secretion

Renal activation of vitamin D

↑ Gastrointestinal Ca absorption

↑ Free serum calcium

In kidney failure, inadequate active vitamin D contributes to compensatory PTH secretion.

Slide 21 · PTH increases bone resorption

Bone is a mineral reservoir in systemic calcium regulation.

PTH promotes development of mature osteoclasts from precursor cells.

Osteoclastic resorption releases mineral from bone.

Persistent excess can damage cortical and trabecular skeletal architecture.

Persistent ↑ PTH

↑ Osteoclastic activity

Net bone resorption

Slide 22 · Osteoclast differentiation links hormone to bone loss

The gland does not act on bone merely by changing renal calcium handling.

PTH excess promotes maturation of osteoclast precursors.

The resulting increase in osteoclastic activity mobilizes calcium.

Excessive sustained resorption underlies characteristic skeletal lesions.

Osteoclast precursors

Mature osteoclasts

Resorb mineralized bone

Slide 23 · PTH targets: Four complementary actions

The physiological output can be summarized without collapsing distinct mechanisms.

Organ/pathway

PTH action

Principal result

Renal calcium

↑ tubular reabsorption

Less urinary Ca loss

Renal phosphate

↑ phosphate excretion

Lower serum phosphate

Vitamin D / intestine

↑ renal vitamin D activation

Greater gut Ca absorption

Bone

↑ osteoclast-mediated resorption

Ca released from bone

Combined response: Increased free serum calcium followed by feedback inhibition.

Slide 24 · Restoring homeostasis requires feedback closure

A physiological response is self-limiting once the stimulus resolves.

Falling ionized calcium

PTH release

Kidney / gut / bone responses

Restored calcium inhibits PTH

Failure of suppression distinguishes autonomous hypersecretion from an appropriate response.

Slide 25 · Interpret the calcium–PTH pair, not PTH alone

An “in-range” PTH can still be physiologically inappropriate.

Under hypercalcemic conditions, normal negative feedback should suppress PTH.

Persistently elevated or nonsuppressed PTH suggests a PTH-dependent process.

Low or undetectable PTH during hypercalcemia suggests a nonparathyroid cause.

High calcium should ↓ PTH

Nonsuppressed PTH = inappropriate

Seek PTH-dependent cause

Slide 26 · The broad functional states of parathyroid disease

The central classification concerns direction and appropriateness of secretion.

Functional state

PTH behavior

Typical consequence

Normal regulation

Feedback responsive

Stable calcium homeostasis

Primary hyperfunction

Autonomous secretion

Hypercalcemia

Secondary hyperfunction

Compensatory secretion

Underlying chronic low-calcium drive

Hypofunction

Insufficient PTH

Hypocalcemia

Tertiary hyperparathyroidism is acquired autonomy after prolonged secondary stimulation.

Slide 27 · Parathyroid lesions often present biochemically

Endocrine output may dominate over local compression.

Parathyroid tumors usually draw attention because of PTH excess.

This differs from the frequent mass presentation of thyroid neoplasms.

Morphologic assessment and biochemical interpretation are complementary.

PTH excess detected

Focused gland evaluation

Histology interpreted clinically

Slide 28 · Hyperparathyroidism has three major categories

Classification asks whether excess secretion is autonomous or compensatory.

Primary: Autonomous PTH production, commonly adenoma or hyperplasia.

Secondary: Compensatory PTH increase in sustained low-calcium states.

Tertiary: Autonomous secretion developing after prolonged secondary hyperfunction.

Primary: Autonomous

Secondary: Compensation

Tertiary: New autonomy

Slide 29 · Primary versus secondary versus tertiary

This contrast prevents conflation of unrelated mechanisms.

Type

Driving mechanism

Representative setting

Primary

Intrinsic autonomous PTH excess

Adenoma / primary hyperplasia

Secondary

Response to chronic hypocalcemic drive

Renal failure / vitamin D deficiency

Tertiary

Acquired persistent autonomy

Long-standing secondary disease

Tertiary disease may produce hypercalcemia despite an initial compensatory origin.

Slide 30 · Primary hyperparathyroidism is usually an adenoma

Parathyroid gland pathology commonly produces an altered hormonal set point.

A solitary sporadic adenoma is the dominant lesion in primary hyperparathyroidism.

Primary hyperplasia is less common and may affect multiple glands.

Carcinoma is rare but requires different morphologic criteria.

Typically one gland

Circumscribed proliferation

Other glands often suppressed

Slide 31 · Adenoma reflects clonal glandular growth

Sporadic adenomas arise through several established molecular mechanisms.

CCND1 rearrangement can increase cyclin D1 expression.

MEN1 tumor-suppressor abnormalities occur in a subset of sporadic tumors.

The genetic mechanism and the biochemical phenotype are different levels of explanation.

CCND1 pathway

MEN1 tumor suppressor

Excess cell proliferation

Slide 32 · CCND1 dysregulation and parathyroid proliferation

A transcriptional rearrangement can enhance a cell-cycle regulator.

Chromosome 11 inversion

CCND1 near PTH regulatory elements

Cyclin D1 overexpression

Increased parathyroid cell proliferation

This is one established route, not the only cause of adenoma.

Slide 33 · Parathyroid adenoma: Expected gross pattern

Anatomical isolation and neighboring tissue help interpretation.

Typically solitary, circumscribed, soft, tan to reddish-brown nodule.

It may be adjacent to the thyroid or at an ectopic site.

Other parathyroid glands are commonly normal-sized or reduced in size.

Typically one gland

Circumscribed proliferation

Other glands often suppressed

Slide 34 · Parathyroid adenoma: Microscopic pattern

The usual adenoma is a relatively uniform chief-cell proliferation.

Sheets of polygonal cells with small central nuclei.

Fat is inconspicuous relative to a typical adult normal gland.

A compressed rim of residual normal parathyroid may remain at the periphery.

Adenoma: Crowded cells, scant fat

Schematic — not a histologic specimen

Slide 35 · Endocrine atypia is not proof of carcinoma

Nuclear appearance alone can be misleading.

Benign adenomas may contain bizarre or pleomorphic nuclei.

Mitoses tend to be rare in typical adenomas.

Demonstrated invasion or metastasis—not isolated cytologic atypia—defines carcinoma in the source.

Nuclear pleomorphism

May occur in adenoma

≠ carcinoma by itself

Slide 36 · Parathyroid hyperplasia is generally multiglandular

Distribution is helpful, but not always definitive.

Primary hyperplasia often affects all four glands, sometimes asymmetrically.

Apparent sparing of one or two glands can mimic a solitary adenoma.

Microscopically, chief-cell or water-clear-cell hyperplasia may be diffuse or nodular.

Multiple glands possible

Asymmetric enlargement

Diffuse or nodular cells

Slide 37 · Adenoma and hyperplasia: Overlapping morphology

Assess the entire gland distribution rather than one microscopic field.

Feature

Adenoma

Hyperplasia

Gland distribution

Usually solitary

Often multiglandular

Stromal fat

Usually reduced

Usually reduced

Cell pattern

Uniform chief-cell sheets typical

Diffuse/multinodular chief cells typical

Practical pitfall

Peripheral residual rim may help

Asymmetry may simulate adenoma

There is no single microscopic feature that always resolves the distinction.

Slide 38 · Carcinoma requires invasive behavior

Parathyroid cancer is not defined by nuclear pleomorphism alone.

Tissue invasion and/or metastasis are the reliable defining features.

Cells may resemble normal parathyroid chief cells.

Gross lesions may be irregular gray-white masses rather than circumscribed nodules.

Irregular infiltrative border

Confirmed tissue invasion

Or distant metastasis

Slide 39 · Atypical parathyroid neoplasm is an intermediate concern

Certain morphologic features are worrisome but insufficient for carcinoma.

Fibrosis, cystic change, and macronucleoli may raise concern.

Without unequivocal invasion or metastasis, the source places such lesions in an atypical category.

Parafibromin deficiency can indicate underlying CDC73 alteration.

Worrisome changes

No proven invasion

Assess CDC73 / parafibromin

Slide 40 · CDC73 and hereditary predisposition

Molecular findings can trigger familial evaluation.

CDC73 encodes parafibromin and is altered in many parathyroid carcinomas.

Germline CDC73 causes hyperparathyroidism–jaw tumor syndrome.

Carcinoma and parafibromin-deficient neoplasms warrant assessment for germline CDC73.

CDC73 abnormality

Parafibromin deficiency

Hereditary assessment

Slide 41 · CASR dysfunction changes the calcium set point

Receptor impairment can mimic a parathyroid hyperfunction pattern.

Familial hypocalciuric hypercalcemia often reflects heterozygous CASR loss of function.

Reduced extracellular-calcium sensitivity permits nonsuppressed PTH despite elevated calcium.

The text notes that many affected people lack typical end-organ effects of hyperparathyroidism.

Defective Ca²⁺ sensing

PTH not appropriately suppressed

Hypercalcemia / low urine Ca

Slide 42 · A biochemical approach to hypercalcemia

Measure intact PTH in relation to elevated serum calcium.

Confirmed hypercalcemia

Concurrent PTH measurement

Elevated / inappropriately normal → PTH dependent

Suppressed → search for nonparathyroid cause

Family history and urine calcium may be relevant when familial hypocalciuric hypercalcemia is considered.

Slide 43 · Why hypercalcemia has different PTH responses

Biochemical patterns point toward distinct mechanisms.

Context

Expected PTH pattern

Interpretation

Primary hyperparathyroidism

High or inappropriately normal

PTH-dependent hypercalcemia

Malignancy-associated hypercalcemia

Low / suppressed

PTH-independent hypercalcemia

Familial hypocalciuric hypercalcemia

Not appropriately suppressed

Altered CASR calcium sensing

PTH-related peptide can mimic PTH effects without elevating true PTH.

Slide 44 · High PTH injures bone when excess persists

Physiologic mobilization becomes pathology under sustained stimulation.

Increased osteoclastic activity drives loss of bone mineral.

Cortical surfaces, including subperiosteal and endosteal areas, are particularly affected.

Prolonged severe disease can produce fibrous replacement and reactive lesions.

Chronic PTH excess

Subperiosteal/endosteal resorption

Cortical bone loss

Slide 45 · Dissecting osteitis is a distinctive bone pattern

Osteoclasts can burrow into trabecular bone.

Osteoclasts tunnel longitudinally within trabeculae.

The resulting resorption has a described “railroad-track” appearance.

Adjacent marrow spaces can be replaced by fibrovascular tissue.

Trabecular tunneling

Resorption tracks

Fibrovascular replacement

Slide 46 · Brown tumors are reactive, not primary bone cancer

Bone fragility and repair create a mass-like lesion.

Bone loss predisposes to microfractures and hemorrhage.

Macrophages and reparative fibrous tissue accumulate around the injury.

Vascularity, hemorrhage, and hemosiderin explain the brown appearance.

Microfracture + hemorrhage

Macrophage / fibrous repair

Brown reactive mass

Slide 47 · Osteitis fibrosa cystica signals severe disease

Several skeletal processes converge in an advanced phenotype.

Excessive osteoclast activity produces resorption.

Peritrabecular fibrosis replaces normal supporting spaces.

Brown tumors and cystic degeneration can accompany the changes.

Osteoclastic resorption

Peritrabecular fibrosis

Brown tumors / cysts

Slide 48 · Renal stones reflect the hypercalcemic milieu

Increased calcium availability can injure the urinary tract.

PTH-associated hypercalcemia favors nephrolithiasis.

Stones can produce pain, obstruction, and secondary renal dysfunction.

Urine calcium excretion may rise despite PTH-mediated renal calcium conservation.

Hypercalcemia

Urinary stone formation

Pain / obstruction

Slide 49 · Nephrocalcinosis is not the same as nephrolithiasis

Distinguish precipitated deposits within renal tissues from formed stones.

Nephrocalcinosis refers to calcium deposition in renal interstitium and tubules.

Nephrolithiasis refers to concretions in the collecting system.

Both may occur during clinically significant hypercalcemia.

Nephrolithiasis = stones

Nephrocalcinosis = deposits

Both may injure kidney

Slide 50 · Multisystem effects of primary PTH excess

The phenotype is broader than bone and kidney disease.

Gastrointestinal symptoms may include constipation, nausea, and pancreatitis.

Neuropsychiatric symptoms include lethargy and mood disturbance.

Weakness, fatigue, and valvular calcification are other reported manifestations.

Bone / urinary tract

Gut / muscle / nerves

Cardiovascular effects

Slide 51 · Incidental hypercalcemia is often the first clue

Laboratory recognition has changed clinical presentation.

Primary hyperparathyroidism commonly presents without striking symptoms.

Severe brown tumors and osteitis fibrosa cystica are consequently less common in diagnosed patients.

Malignancy remains an important competing cause of symptomatic hypercalcemia.

Incidentally high calcium

PTH–calcium interpretation

Potentially silent pathology

Slide 52 · Secondary hyperparathyroidism is compensatory

A persistently low calcium drive stimulates intact glands.

Renal insufficiency is a common cause.

Vitamin D deficiency, inadequate calcium intake, and malabsorption are other examples.

Unlike primary disease, the initiating problem is usually extrinsic to parathyroid tissue.

Chronic low-calcium drive

Compensatory ↑ PTH

Glandular hyperplasia

Slide 53 · Renal failure drives secondary PTH secretion

Phosphate retention and impaired vitamin D activation converge.

Declining renal function

↑ Phosphate + ↓ active vitamin D

Lower ionized calcium drive

Compensatory ↑ PTH

Vitamin D deficiency also removes a suppressive influence on parathyroid growth and secretion.

Slide 54 · Secondary hyperplasia changes gland morphology

Chronic stimulation is visible at the tissue level.

Parathyroid glands become hypercellular and may enlarge asymmetrically.

Chief-cell and water-clear-cell proliferation may be diffuse or multinodular.

Stromal fat decreases; Adenoma and hyperplasia may overlap histologically.

Multiple glands possible

Asymmetric enlargement

Diffuse or nodular cells

Slide 55 · Tertiary hyperparathyroidism follows chronic drive

The gland may eventually become autonomous.

A minority of patients with long-standing secondary hyperparathyroidism develop persistent autonomous PTH production.

Hypercalcemia can then supervene.

The classification depends on disease history, not only one histologic field.

Long-standing secondary state

Autonomous PTH secretion

Hypercalcemia possible

Slide 56 · PTH deficiency produces hypocalcemia

Loss of normal parathyroid output is a different pathophysiologic problem.

Insufficient PTH prevents the usual corrective response to low calcium.

The resulting hypocalcemia increases neuromuscular excitability.

Common clinical context is inadvertent gland loss during neck surgery.

Inadequate PTH

Hypocalcemia

Tetany / systemic effects

Slide 57 · Postoperative hypoparathyroidism

Anatomic proximity creates the risk.

Accidental parathyroid removal during thyroid or neck surgery can produce PTH deficiency.

Extensive removal during parathyroid surgery may have the same result.

Embryologic and anatomic variation complicates gland preservation.

Thyroid or neck surgery

Gland removal or excess resection

Low PTH / low calcium

Slide 58 · Autoimmune and genetic causes of low PTH

Not all parathyroid failure is acquired by surgery.

APS-1, caused by AIRE variants, may include candidiasis, hypoparathyroidism, and adrenal insufficiency.

Activating CASR variants suppress PTH through excessive calcium sensing.

PTH processing defects and impaired parathyroid development are rarer mechanisms.

AIRE / CASR / PTH / GCM2

Distinct molecular defects

Deficient PTH action

Slide 59 · CASR gain versus loss of function

Opposite receptor defects shift the endocrine calcium set point.

CASR change

Sensing behavior

Associated pattern

Gain of function

Senses calcium too strongly

PTH suppressed; Hypocalcemia

Heterozygous loss of function

Senses calcium insufficiently

Nonsuppressed PTH; FHH

Severe biallelic loss

Very impaired calcium sensing

Severe neonatal hyperparathyroidism

Biochemical direction follows the receptor defect rather than a simple change in cell number.

Slide 60 · Hypocalcemia manifests as tetany

Reduced calcium alters neuromuscular excitability.

Paresthesias, circumoral numbness, and carpopedal spasm are typical.

Severe episodes may lead to laryngospasm or seizures.

Duration and severity determine the broader clinical phenotype.

Tingling / paresthesia

Carpopedal spasm

Seizures / laryngospasm

Slide 61 · Chvostek and Trousseau signs

Clinical elicitation demonstrates latent neuromuscular irritability.

Chvostek sign: Facial muscle contraction after tapping over the facial nerve.

Trousseau sign: Carpal spasm during prolonged inflation of a blood-pressure cuff.

Neither sign substitutes for biochemical assessment of calcium status.

Facial nerve tapping

Cuff-provoked carpal spasm

Correlate with serum Ca

Slide 62 · Chronic hypocalcemia affects multiple tissues

Sustained deficiency produces findings beyond tetany.

Basal ganglia calcification and cataracts are described consequences.

Electrocardiography may show prolongation of the QT interval.

Early-life disease may disrupt dental development and eruption.

Basal ganglia / lens

Cardiac QT prolongation

Developing teeth

Slide 63 · Low calcium: Deficient PTH or resistant target?

Both patterns can produce hypocalcemia, but the hormone response differs.

Disorder

PTH concentration

Pathophysiology

Hypoparathyroidism

Low / insufficient

Inadequate glandular secretion

Pseudohypoparathyroidism

Normal or high

End-organ resistance to PTH

Appropriate response to low Ca

Increases

Preserved gland feedback

Elevated PTH does not guarantee effective downstream hormone action.

Slide 64 · Case: Persistent hypercalcemia

A patient has incidentally detected elevated calcium. Concurrent PTH is not suppressed.

Why is the measured PTH physiologically inappropriate?

Which broad causes of PTH-dependent hypercalcemia should be considered?

Normal feedback should suppress PTH in hypercalcemia. Consider primary parathyroid hyperfunction and, in the appropriate context, altered calcium sensing such as familial hypocalciuric hypercalcemia.

Slide 65 · Case: Renal impairment and elevated PTH

A patient with chronic renal insufficiency has raised phosphate and elevated PTH.

What biochemical pathways stimulate the glands?

What tissue change may develop in the parathyroids?

Phosphate retention plus inadequate active vitamin D contribute to a hypocalcemic drive and compensatory PTH. Chronic stimulation produces gland hypercellularity, often multiglandular.

Slide 66 · Case: Symptoms after thyroid surgery

A patient develops circumoral tingling and carpopedal spasm after thyroid surgery.

What endocrine complication should be suspected?

Why does low calcium cause these clinical findings?

Consider postoperative hypoparathyroidism. Inadequate PTH produces hypocalcemia with neuromuscular irritability; Confirm biochemically.

Slide 67 · Integrated interpretation: PTH and calcium

A framework for connecting physiology with pathology.

Calcium state

PTH pattern

Principal consideration

High

Nonsuppressed

Primary/autonomous PTH process or abnormal sensing

High

Suppressed

Nonparathyroid hypercalcemia

Low

Inadequate / low

Hypoparathyroidism

Low

Appropriately high

Compensatory drive or target resistance

Interpret with phosphate, renal function, vitamin D context, and clinical history.

Slide 68 · Core distinctions for pathology practice

Morphology and function must be interpreted in the same clinical frame.

Chief cells secrete PTH; Oxyphil cells are mitochondria rich.

PTH raises calcium by coordinated renal, vitamin D–intestinal, and skeletal pathways.

Adenoma is usually solitary; Hyperplasia is often multiglandular.

Unequivocal invasion or metastasis—not nuclear atypia alone—identifies carcinoma.

Slide 69 · References

Robbins, Cotran & Kumar: Pathologic Basis of Disease.

11th edition. Elsevier; 2026.

Endocrine system: parathyroid anatomy, physiology, and disorders.

This teaching deck uses edited explanations and original editable schematics; no textbook images reproduced.